Abo Bibliothek: Guest
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen
Critical Reviews™ in Immunology
Impact-faktor: 1.352 5-jähriger Impact-Faktor: 3.347 SJR: 0.657 SNIP: 0.55 CiteScore™: 2.19

ISSN Druckformat: 1040-8401
ISSN Online: 2162-6472

Volumes:
Volumen 39, 2019 Volumen 38, 2018 Volumen 37, 2017 Volumen 36, 2016 Volumen 35, 2015 Volumen 34, 2014 Volumen 33, 2013 Volumen 32, 2012 Volumen 31, 2011 Volumen 30, 2010 Volumen 29, 2009 Volumen 28, 2008 Volumen 27, 2007 Volumen 26, 2006 Volumen 25, 2005 Volumen 24, 2004 Volumen 23, 2003 Volumen 22, 2002 Volumen 21, 2001 Volumen 20, 2000 Volumen 19, 1999 Volumen 18, 1998 Volumen 17, 1997 Volumen 16, 1996 Volumen 15, 1995 Volumen 14, 1994

Critical Reviews™ in Immunology

Ausgabe kaufen $188.00 Volumen 30, 2010 Ausgabe 2

DOI: 10.1615/CritRevImmunol.v30.i2

Inhaltsverzeichnis:

Novel Innate Immune Functions Revealed by Dynamic, Real-Time Live Imaging of Bacterial Infections
Keira Melican, Jorrit Boekel, Monica Ryden-Aulin, Agneta Richter-Dahlfors
pages 107-117
DOI: 10.1615/CritRevImmunol.v30.i2.10
The Pathogenesis of Murine Coronavirus Infection of the Central Nervous System
Martin P. Hosking, Thomas E. Lane
pages 119-130
DOI: 10.1615/CritRevImmunol.v30.i2.20
Staphylococcal Superantigen Super-Domains in Immune Evasion
Ries Langley, Deepa Patel, Nicola Jackson, Fiona Clow, John D. Fraser
pages 149-165
DOI: 10.1615/CritRevImmunol.v30.i2.40
Mode of Action of Botulinum Neurotoxins: Current Vaccination Strategies and Molecular Immune Recognition
K. Roger Aoki, Leonard A. Smith, M. Zouhair Atassi
pages 167-187
DOI: 10.1615/CritRevImmunol.v30.i2.50
Induction of Th17 Cellular Immunity With a Novel Nanoemulsion Adjuvant
Anna U. Bielinska, Michele Gerber, Luz P. Blanco, Paul E. Makidon, Katarzyna W. Janczak, Michael Beer, Benjamin Swanson, James R. Baker, Jr.
pages 189-199
DOI: 10.1615/CritRevImmunol.v30.i2.60
Biomarkers for Serum Diagnosis of Infectious Diseases and Their Potential Application in Novel Sensor Platforms
Luiz R. Goulart, Carlos U. Vieira, Ana Paula P. Freschi, Fausto E. Capparelli, Patricia T. Fujimura, Juliana F. Almeida, Lucas F. Ferreira, Isabela M.B. Goulart, Ana Graci Brito-Madurro, Joao M. Madurro
pages 201-222
DOI: 10.1615/CritRevImmunol.v30.i2.70

Critical Reviews™ in Immunology

Model for the recruitment of inducer-specific TNF-α gene enhanceosome in T lymphocytes., Vol. 29, Iss.2, Viral Mechanisms Involved in the TranscriptionalCBP/p300 Regulation of Inflammat..... Model for the recruitment of inducer-specific TNF-α gene enhanceosome in T lymphocytes., Vol. 29, Iss.2, Viral Mechanisms Involved in the TranscriptionalCBP/p300 Regulation of Inflammat..... Viral Mechanisms Involved in the Transcriptional CBP/р300 Regulation of Inflammatory and Immune Responses
Activation of several B cells is necessary for exosome release.Vol. 29, Iss. 3, Exosome Release by Primary B Cells. Activation of several B cells is necessary for exosome release.Vol. 29, Iss. 3, Exosome Release by Primary B Cells. Exosome Release by Primary B Cells
Homology model of human GrM. Vol. 29, Iss. 4, The Biology of Granzyme M: A Serine Protease with Unique Features. Homology model of human GrM. Vol. 29, Iss. 4, The Biology of Granzyme M: A Serine Protease with Unique Features. Biology of Granzyme M: A Serine Protease with Unique Features
(A) Gap-junction formation, (B) A three-dimensional collagen matrix Vol. 30, Iss. 6, Endothelial Cells as Key Determinants of the Tumor Microenvironment. (A) Gap-junction formation, (B) A three-dimensional collagen matrix Vol. 30, Iss. 6, Endothelial Cells as Key Determinants of the Tumor Microenvironment. Endothelial Cells as Key Determinants of the Tumor Microenvironment: Interaction with Tumor Cells, Extracellular Matrix and Immune Killer Cells
Biphasic HCV RNA decline after IFN treatment of chronic hepatitis C. Vol. 30, Iss. 2, Treatment of Hepatitis C Virus Infection with Interferon and Small Molecule Direct Antivirals. Biphasic HCV RNA decline after IFN treatment of chronic hepatitis C. Vol. 30,  Iss. 2, Treatment of Hepatitis C Virus Infection with Interferon and Small Molecule Direct Antivirals. Treatment of Hepatitis C Virus Infection With Interferon and Small Molecule Direct Antivirals: Viral Kinetics and Modeling